Photocure ASA
ISIN: NO0010000045 | Ticker: PHO
Our story began in 1997 at our headquarters in Oslo, Norway. Photocure began with a focus on developing and improving photodynamic technology. Over the years our focus changed, still grounded in the world of photodynamic technology, we evolved our vision to become a bladder cancer speciality company.
In collaboration with our partners, we are dedicated to improving outcomes for patients all around the world. It’s a dedication that can be seen in our products and services, providing transformative solutions that improve the management of bladder cancer, as well as helping us become a global leader in the field.
For too long patients with bladder cancer have had limited options, leaving them living in fear of recurrence and progression. This is why we are The Bladder Cancer Company and why every single person at Photocure is focused on a single mission – making a continuous, positive impact on the lives of our patients, the people we work with, and society as a whole.
1993
Served areaWorldwide
HeadquartersHoffsveien 4, 0275 Oslo – Norway
27,120,820
IPOJan. 1, 2000
Stock exchange(s)Euronext Oslo